Literature DB >> 23775653

XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?

Wilhelm Woessmann1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23775653     DOI： 10.1002/hon.2069

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  3 in total

1.  Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study.

Authors:  Matthew J Ehrhardt; Yan Chen; John T Sandlund; Elizabeth C Bluhm; Robert J Hayashi; Kerri Becktell; Wendy M Leisenring; Monika L Metzger; Kirsten K Ness; Kevin R Krull; Kevin C Oeffinger; Todd M Gibson; Mitchell S Cairo; Thomas G Gross; Leslie L Robison; Gregory T Armstrong; Yutaka Yasui; Melissa M Hudson; Daniel A Mulrooney
Journal:  J Clin Oncol       Date:  2019-07-08       Impact factor: 44.544

2.  Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients.

Authors:  Swati Naik; Caridad A Martinez; Bilal Omer; Ghadir Sasa; Khaled Yassine; Carl E Allen; Kala Kamdar; Robert Orth; Mengfen Wu; Kathryn Leung; Stephen Gottschalk; Malcolm K Brenner; Helen E Heslop; Robert A Krance
Journal:  Blood Adv       Date:  2019-09-24

3.  Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children.

Authors:  Jun Li; Xiao-Wen Zhai; Hong-Sheng Wang; Xiao-Wen Qian; Hui Miao; Xiao-Hua Zhu
Journal:  Med Sci Monit       Date:  2016-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.